| dc.contributor.advisor |
Roberts , Bryan R . , 1939 - |
|
| dc.contributor.advisor |
Buckley , Cynthia J . |
|
| dc.contributor.committeeMember |
Ward , Peter |
|
| dc.contributor.committeeMember |
Ugalde , Antonio |
|
| dc.contributor.committeeMember |
Charrad , Mounira |
|
| dc.contributor.committeeMember |
Wilson , Robert |
|
| dc.creator |
Flynn , Matthew Brian |
|
| dc.date.accessioned |
2011 -08 -01T19 :34 :43Z |
|
| dc.date.available |
2011 -08 -01T19 :34 :43Z |
|
| dc.date.created |
2010 -12 |
|
| dc.date.issued |
2011 -08 -01 |
|
| dc.date.submitted |
December 2010 |
|
| dc.identifier.uri |
http : / /hdl .handle .net /2152 /ETD -UT -2010 -12 -2257 |
|
| dc.description.abstract |
The Acquired Immune Deficiency Syndrome (AIDS ) caused by the human immunodeficiency virus (HIV ) represents one of the biggest challenges facing today's globalized world . Meanwhile , transnational drug companies have strengthened their market positions in developing countries as a result of the Agreement on Trade -Related Aspects of Intellectual Property (or TRIPS ) . Patent protection provided by TRIPS has led to higher prices and reduced access to essential medicines . Low - and middle -income countries are under increased pressure to provide expensive life -saving medicines to their citizens . Brazil's AIDS program is deemed successful in reducing morbidity and mortality rates through universal provision of free AIDS medicines . The program's sustainability came under threat as the result of TRIPS , pressures by transnational corporations , and trade threats by the US government . The research question that drove my dissertation centered on the impact of these threats on policy space available to Brazilian government to sustain its universal social program . How has the incorporation of patent protections for drugs affected the ability of local firms to develop pharmaceutical technology and challenged states like Brazil to fulfill social democratic obligations ? Under what conditions can a developing country challenge the interests of transnational drug companies ? I employed mixed methods for gathering and analyzing data . These included ethnographic field techniques , content analysis , and archival research . My findings are threefold . First , TRIPS has increased the power of foreign firms to secure monopoly positions in Brazil’s drug markets and weakened Brazil's labs to quickly make generic copies of essential medicines . Second , policy space , though curtailed due to external pressures and treaty obligations , expanded through the development of symbolic power , or what I call "reputational dividends ," based on a successful social program . Third , by adroitly marketing its banner AIDS program by employing human rights principles , health officials constructed a triple alliance between the state , local private drug manufacturers , and domestic activists tied into transnational advocacy networks . I employ institutional and power analyses to examine the changing sources of power for transnational capital , social movements , and state actors , as well as analyze the impact patent protection has on the ability of Brazilian firms to produce medicines locally . I posit that globalization results in the formation of strong domestic coalitions who are capable of exploiting the "reputational dividends" of a successful social program in order to contest transnational corporate power . This symbolic form of power appears particularly well -disposed for "middle -income" countries that lack the material forms of power held by a global hegemon or transnational corporations . |
|
| dc.format.mimetype |
application /pdf |
|
| dc.language.iso |
eng |
|
| dc.subject |
Globalization |
|
| dc.subject |
Brazil |
|
| dc.subject |
HIV /AIDS |
|
| dc.subject |
Intellectual property |
|
| dc.subject |
State autonomy |
|
| dc.subject |
Agreement on Trade -Related Aspects of Intellectual Property (TRIPS ) |
|
| dc.subject |
HIV infections |
|
| dc.subject |
AIDS (Disease ) |
|
| dc.subject |
Drug patents |
|
| dc.subject |
Pharmaceuticals |
|
| dc.title |
Pharmaceutical governance in Brazil : globalization , institutions and AIDS |
|
| dc.description.department |
Sociology |
|
| dc.type.genre |
thesis |
* |
| dc.type.material |
text |
* |
| thesis.degree.name |
Doctor of Philosophy |
|
| thesis.degree.level |
Doctoral |
|
| thesis.degree.discipline |
Sociology |
|
| thesis.degree.grantor |
University of Texas at Austin |
|
| thesis.degree.department |
Sociology |
|
| dc.date.updated |
2011 -08 -01T19 :34 :52Z |
|
| dc.identifier.slug |
2152 /ETD -UT -2010 -12 -2257 |
|